The effectiveness of wet-cupping for nonspecific low back pain in Iran: a randomized controlled trial.
OBJECTIVE
To determine the efficacy of wet-cupping for treating persistent nonspecific low back pain.


BACKGROUND
Wet-cupping therapy is one of the oldest known medical techniques. It is still used in several contemporary societies. Very minimal empirical study has been conducted on its efficacy.


METHODS
Randomized controlled trial with two parallel groups. Patients in the experimental group were offered the option of referral to the wet-cupping service; all accepted that option. The control group received usual care.


METHODS
Medical clinic in Kermanshah, Iran.


METHODS
In total, 98 patients aged 17-68 years with nonspecific low back pain; 48 were randomly assigned to experimental group and 50 to the control group.


METHODS
Patients in the experimental group were prescribed a series of three staged wet-cupping treatments, placed at 3 days intervals (i.e., 0, 3, and 6 days). Patients in the control group received usual care from their general practitioner.


METHODS
Three outcomes assessed at baseline and again 3 months following intervention: the McGill Present Pain Index, Oswestry Pain Disability Index, and the Medication Quantification Scale.


RESULTS
Wet-cupping care was associated with clinically significant improvement at 3-month follow-up. The experimental group who received wet-cupping care had significantly lower levels of pain intensity ([95% confidence interval (CI) 1.72-2.60] mean difference=2.17, p<0.01), pain-related disability (95% CI=11.18-18.82, means difference=14.99, p<0.01), and medication use (95% CI=3.60-9.50, mean difference=6.55, p<0.01) than the control group. The differences in all three measures were maintained after controlling for age, gender, and duration of lower back pain in regression models (p<0.01).


CONCLUSIONS
Traditional wet-cupping care delivered in a primary care setting was safe and acceptable to patients with nonspecific low back pain. Wet-cupping care was significantly more effective in reducing bodily pain than usual care at 3-month follow-up.
Farhadi
Khosro
K
Department of Anesthesiology, Critical Care and Pain Management, Pain research center, Kermanshah University of Medical Sciences, Iran.
Schwebel
David C
DC
Saeb
Morteza
M
Choubsaz
Mansour
M
Mohammadi
Reza
R
Ahmadi
Alireza
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001815:Bloodletting; D005260:Female; D006801:Humans; D007492:Iran; D017116:Low Back Pain / Q000628:therapy*; D008297:Male; D020393:Manipulation, Spinal; D008875:Middle Aged; D010147:Pain Measurement; D026741:Physical Therapy Modalities; D012015:Reference Standards; D012146:Rest; D055815:Young Adult
D000893:Anti-Inflammatory Agents